INS and Alzheimer disease: Various factors have been suggested to contribute to this association, including altered insulin signaling, hyperglycemia, advanced glycation, chronic low-grade inflammation, small vessel disease (SVD), large vessel disease, and Alzheimer’s disease (AD) pathology2, but specific pathways and their relationship with AD biomarkers are complex and not fully understood.